Processa Pharmaceuticals, Inc. current report, 06 December 2018

Business Context and Reporting Period

Company: Processa Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 6, 2018
Reporting Period: Event occurred on December 5, 2018, with trading changes effective December 6, 2018.
Context: The company is an emerging growth company incorporated in Delaware. This filing addresses a change in the listing status of its common stock.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.

Material Changes

  • Listing Transfer: Processa Pharmaceuticals, Inc. received notice that its common stock will commence trading on the OTCQB market.
  • Previous Listing: The stock previously traded on the OTC Pink Marketplace.
  • Trading Symbol: The existing symbol "PCSA" remains unchanged.
  • Effective Date: Trading on the OTCQB began at the market opening on December 6, 2018.

Guidance, Outlook, and Risks

Management Commentary: The filing incorporates a press release (Exhibit 99.1) regarding the transfer of listing. No specific financial guidance or operational outlook is detailed within the text of this 8-K.

Risks and Contingencies: The document notes that the information in Item 7.01 (referenced in Item 8.01) and the attached press release are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section, nor are they incorporated by reference in other filings unless expressly stated.

Investor Verification Checklist

  • Verify the current trading status and liquidity of "PCSA" on the OTCQB market.
  • Review the attached Press Release (Exhibit 99.1) for the specific reasons behind the transfer from the OTC Pink Marketplace to OTCQB.
  • Confirm if the transfer to OTCQB was voluntary or mandated by the previous marketplace due to non-compliance with listing standards.
  • Check subsequent filings for any financial updates, as this 8-K contains no financial data.